临床诊疗
目的 观察阵发性房颤(PAF)环肺静脉电隔离术(CPVI术)治疗对左心房结构和功能的影响。方法 对63例PAF患者行CPVI术,超声心动图测定术前及术后3天、6个月时左心房内径(LAD)、左心房面积(LAA) 、左心房最大容积(LAVmax)、收缩期前容积(LAVp)、最小容积(LAVmin),测量二尖瓣血流频谱A峰流速(VA)、左心房被动射血分数(LAPEF)、主动射血分数(LAAEF)、扩张指数 (LaexpI)。结果 63例患者中54例于术后6个月时仍维持窦性心律,维持窦性心律者 LAD、LAA、LAVmax、LAVp、LAVmin对比术前减小 (P<0.05); VA、LAAEF术后3天降低(P<0.05),6个月对比术前无变化(P>0.05); LaexpI、LAPEF术后3天及6个月时均无改变(P>0.05)。结论 阵发性房颤环肺静脉电隔离术后左心房结构逆重构,早期辅泵功能下降,6个月时左心房功能未受影响。
论著
目的 回顾分析我院胆石症患者个体化治疗方案的效果。方法 2006年8月—2015年1月,我院治疗不同类型胆石症患者3176例,其中胆囊结石2987例,其他类型胆管结石患者189例,定期复查B超等影像检查并最长随访9年,从并发症和术后主观症状、残石率和结石复发率等情况,了解治疗效果。结果 全组患者均手术成功, 大部分自觉症状明显好转,胆囊结石患者平均手术时间(35.7±14.5)分钟, 平均住院时间(3.5±2.5)天;胆管结石平均手术时间(70.3±31.5)分钟,平均住院时间(9.5±4.7)天。胆囊结石残留率0.1%,保胆术式结石复发率8.1%;胆管结石残留率3.7%和复发率5.5%。结论 胆石症患者病情繁杂多样,尤其是肝内胆管结石,治疗需要个体化。
Objective To retrospective analyze the effect of individualization treatment of calculus of cholelithiasis patients. Methods 3176 patients with different kind of cholelithiasis were treated in our hospital during Aug 2006 to Jan, 2015, including 2987 gallstone patients and 189 calculus of bile duct patients. Periodic review of B ultrasound and follow-up was taken after the surgery for 9 years, recording and analyzing intraoperative and postoperative complications, symptoms, residual stones and stone recurrence rate and other, and to evaluate the therapeutic effect. Results Surgeries of all the patients were performed successfully. Postoperative follow-up indicated that symptoms were relieved. The operative duration of gallstone patients was (35.7 ± 14.5) min, and the average hospitalization time was (3.5±2.5) days. The operative duration of calculus of bile duct patients was (70.3± 31.5) min, and the average hospitalization time was (9.5±4.7) days. And the calculus residual rate and recurrence rate of gallstone patients was 0.1% and 8.1% individually. The calculus residual rate and recurrence rate of calculus of bile duct patients was 3.7% and 5.5%. Conclusion Conditions of calculus of cholelithiasis patients are complicated, especially calculus of intrahepatic duct patient. It is necessary to take individual treatment schedule for them.
论著
目的 探讨莫西沙星结合抗结核药物治疗糖尿病合并肺结核患者的临床疗效分析。方法 将本组126例糖尿病合并肺结核患者分为对照组(n=63)和观察组(n=63);对照组给予降血糖治疗及抗结核药物降糖治疗,观察组在对照组治疗基础上服用莫西沙星;两组治疗均以3个月为一个疗程,2个疗程后统计疗效。结果 观察组总有效率(93.65%)高于对照组(76.19%),差异有统计学意义(P<0.05);观察组痰菌检测转阴率(94.59%)高于对照组(79.49%),差异有统计学意义(P<0.05);治疗过程中观察组与对照组出现不良反应情况相比较差异无统计学意义(P>0.05)。结论 莫西沙星结合抗结核药物治疗糖尿病合并肺结核疗效显著,具有较强的杀菌作用。
Objective To investigate the clinical efficacy of moxifloxacin combining with antituberculosis drug in the treatment of diabetic patients with pulmonary tuberculosis. Methods A group of 126 patients of diabetes complicated with pulmonary tuberculosis were divided into control group (n=63) and observation group (n=63); the control group was given by hypoglycemic therapy and therapy of antituberculosis drug only, and the observation group was also given by moxifloxacin; two groups were treated for 3 months as a course.The clinical efficacy was evaluated after 2 courses. Results The total effective rate of observation group (93.65%) was significantly higher than that of the control group (80.95%), and the difference was statistically significant (P<0.05); the negative sputum rate of observation group (94.59%) was higher than that of the control group (79.49%), and the difference was statistically significant (P<0.05); there was no statistically significant difference between the observation group and the control group in adverse effects. Conclusion The curative effect of moxifloxacin combining with antituberculosis drug in the treatment of diabetes mellitus complicated with pulmonary tuberculosis was good, with strong bactericidal effect.
综述
目的 研讨阿司匹林广泛用于高危血栓、栓塞抗凝的预防治疗应用。方法 查阅参考文献,结合临床实践,新口服抗凝药疗效终点卒中和体循环栓塞方面为基准。结果 界於CHADS2和CHA2DS2-VASc 评分所涵盖的风险和差异因素,后期华法林与新口服抗凝药可能取舍或并存。结论 在危险分层,卒中抗拴防凝治疗中,我国房颤患者不建议继续服用阿司匹林。
Objective To Study and discuss the applications for prevention and treatment of high risky thrombosis and embolism anticoagulation of Aspirin. Methods Combining literature consultation and clinical practice,making stroke and general circulation embolism of oral anticoagulant curative effect terminal point as the base. Results According to the risky and different factors covered by CHADS2 and CHA2DS2-VASc in the later stage, warfarin and the new oral anticoagulant can be taken together or abandon one of them. Conclusion In the risky factors classification and stroke anticoagulant therapy, we suggest that the atrial fibrillation patients should not take Aspirin.
临床诊疗
目的 研究经后路椎体间植骨融合术治疗老年退变性腰椎滑脱合并腰椎管狭窄症的临床效果。方法 将我院110例老年退变性腰椎滑脱合并腰椎管狭窄症患者抽签分为研究组与对照组,两组均为55例,研究组采取经后路椎体间植骨融合术治疗,对照组采取传统手术治疗,比较两组临床效果、Prolo评分及术中出血量、术后引流量、术后卧床时间及手术时间差异。结果 研究组总有效率与对照组总有效率分别为90.91%、92.73%,比较无统计学意义(P>0.05);术后研究组Prolo功能、症状、总分均高于对照组(P<0.05),滑移率比较无统计学意义(P>0.05);研究组术中出血、术后引流量及术后卧床时间低于对照组(P<0.05),手术时间比较无统计学意义(P>0.05)。结论 经后路椎体间植骨融合术治疗老年退变性腰椎滑脱合并腰椎管狭窄症疗效确切,短期效果与传统术式相似,但可加快患者功能恢复,降低手术过强应激反应,具有较高的临床价值。
临床诊疗
目的 观察有创-无创序贯通气治疗慢性阻塞性疾病(COPD)急性加重并呼吸衰竭的疗效。方法 选取2013年3月—2015年3月在兴宁市人民医院呼吸科收治的COPD急性加重并II型呼吸衰竭、需行机械通气的患者80例,随机进行有创-无创序贯通气治疗组A和单一有创通气治疗组B,两组除了机械通气的方式不同之外,其他的常规治疗均相同,主要观察两组患者进行相关机械通气方式前后的呼吸、循环及血气指标的变化情况以及进行机械通气的总时间和住院时间及呼吸机相关肺炎(VAP)的发生例数。结果 治疗组患者的血气、呼吸及循环内的各项生化指标改善程度均与对照组无统计学意义(P>0.05),同时治疗组患者的VAP的发生率,总的住院时间,进行机械通气的总时间少于对照组患者,有统计学意义(P<0.05)。结论 采用有创-无创序贯通气治疗慢性阻塞性疾病(COPD)急性加重并呼吸衰竭综合治疗效果要好于采用单一有创通气治疗,值得临床推广应用。
临床诊疗
目的 探讨盆底肌康复仪配合中药补中益气汤对盆底功能障碍性疾病的治疗疗效。方法 对300例女性盆底功能障碍性疾病(FPFD)的患者采用盆底肌康复仪同时配合中药补中益气汤协同治疗从而弥补单纯盆底康复治疗不足。结果 产后一年内的早期盆底肌力松弛治愈率达83.82%; SUI组治疗后的临床症状控制效果及盆底肌力、持续时间优于POP组,P<0.01。结论 产后及时、早期干预盆底肌功能可有效防止盆底功能障碍性疾病的不良发展,同时配合经典方补中益气汤可益气、升阳举陷调理脏腑机能产生协同作用。
临床诊疗
目的 探讨DPP-4抑制剂联合二甲双胍治疗2型糖尿病的临床疗效及安全性。方法 选取医院近3年收治的糖尿病病人70例,随机分为对照组(35例)和治疗组(35例),对照组给予二甲双胍治疗,治疗组给予二甲双胍联合DPP-4抑制剂控制血糖,经3个月治疗,比较治疗后血糖指标、胰岛功能指标及低血糖、不良反应情况。结果 对照组和治疗组治疗后FPG、2hPG、HbA1c水平均有降低,治疗组治疗后血糖检测指标优于对照组(P>0.05)。胰岛功能监测显示治疗组治疗后空腹胰岛素、服糖后2小时胰岛素浓度升高优于对照组,胰高血糖素水平降低幅度大于对照组,治疗前后胰岛素及胰高血糖素均有变化,组间比较P>0.05,有临床意义。治疗期间两组患者均未发生低血糖、药物不良反应。结论 DPP-4抑制剂联合二甲双胍可显著提高降糖效果,改善胰岛功能,并且无低血糖、药物不良反应发生。
临床诊疗
目的 动态观察乳腺癌患者辅助内分泌治疗5年后的血脂及肝功能水平的变化,探求辅助内分泌治疗与高脂血症及脂肪肝发病率的关系。方法 56例乳腺癌患者实行辅助内分泌治疗,术后随访5年动态抽血测定其总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL)、高密度脂蛋白胆固醇(HDL)及谷草转氨酶(AST)、谷丙转氨酶(ALT)、直接胆红素(DBIL)、总胆红素(TBIL)等参数的变化,B超监测其肝脏变化。结果 经过2年内分泌治疗TG由(1.203±0.723)mmol/L上升至(1.701±1.271)mmol/L,5年内分泌治疗后TG降至(1.389±0.706)mmol/L。经过2年内分泌治疗LDL由(2.497±0.990)mmol/L上升至(2.950±0.984)mmol/L,5年内分泌治疗后LDL为(2.867±0.886)mmol/L。结论 辅助内分泌治疗2年会导致其TG和LDL的升高,5年随访仅发现LDL升高,辅助内分泌治疗会增加乳腺癌患者诱发心血管疾病的风险。
论著
目的 分析呼吸康复治疗对农村地区慢性阻塞性肺疾病(COPD)稳定期患者BODE评分系统的影响。方法 将我院收治的60例COPD稳定期患者作为研究对象,随机分为对照组与观察组,每组30例。对照组常规治疗,观察组则给予呼吸康复治疗方案。比较两组患者治疗前后BOBE评分系统的变化。结果 治疗后,观察组BMI、FEV1%、MMRC分级、6MWD分别为(22.4±1.1)kg/m2,(68.6±3.6)%,(1.3±0.2)级,(256.3±36.3)m,BODE指数评分降低至(3.4±1.0)分,ADL为(78.2±6.4)分,QOL为(67.8±2.6)分,与对照组相比差异有统计学意义(P<0.05);且观察组炎性因子水平下降幅度高于对照组(P<0.05)。结论 在农村地区COPD稳定期患者的临床治疗中,采用呼吸康复治疗方案,患者BODE评分系统指标改善显著,值得推广。
Objective To analyze the influence of respiratory rehabilitation treatment on BODE coring system of patients with chronic obstructive pulmonary disease (COPD) in stable phase in rural areas. Methods 60 patients with COPD in stable phase admitted into the hospital were selected as the research object and were randomly divided into control group and observation group with 30 cases in each. The control group received conventional treatment while the observation group received respiratory rehabilitation treatment. The changes of BOBE coring system in the two groups before and after the treatment were compared. Results After the treatment, BMI, FEV1% MMRC classification and 6MWD of the observation group were (22.4±1.1) kg/m2, (68.6±3.6)%, (1.3±0.2) and (256.3±36.3) m respectively. The BODE index score decreased to (3.4±1.0), ADL (78.2±6.4), and QOL (67.8 + 2.6).compared with those of the control group, the difference was statistically significant (P< 0.05). And the decline level of inflammatory factors in the observation group was significantly higher than that of the control group (P<0.05). Conclusion In the clinical treatment of patients with COPD in stable phase in rural areas, respiratory rehabilitation treatment were adopted, the improvement of BOBE coring system indexes is significant. It is worthy to be popularized.